Tweet
<img alt="" height="1" width="1" />
Roche, Curis Hedgehog Drug Fails Colon Cancer Trial
BusinessWeek
June 16 (Bloomberg) -- Roche Holding AG and Curis Inc.'s experimental treatment for cancers with an overactive gene mutation failed to help patients in a study of colorectal tumors. Curis's shares fell 45 percent. ...
Curis Tumbles As Roche Colon Cancer Trial FailsWall Street Journal
Curis says cancer drug fails in mid-stage trialReuters
Curis Drug Fails Mid-Stage Colon Cancer Study: BioBuzzTheStreet.com
Interactive Investor -MarketWatch (press release) -Reuters UK
all 37 news articles »
More...